20 May 2013
Keywords: lilly, licenses, gastrin, agents, tt, drug, major
Article | 24 March 2008
US drug major Eli Lilly has entered into a licensing and collaboration agreement with Transition Therapeutics granting the former exclusive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.